DSOL (Drug Free Solution) EBIT: $-0.87 Mil (TTM As of Feb. 2014)


What is Drug Free Solution EBIT?

Drug Free Solution DSOL EBIT is $-0.87 Mil as of Feb. 2014.

Drug Free Solution's earnings before interest and taxes (EBIT) for the three months ended in Feb. 2014 was $-0.12 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Feb. 2014 was $-0.87 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Drug Free Solution's annualized ROC % for the quarter that ended in Feb. 2014 was -202.96%. Drug Free Solution's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2014 was -1,315.07%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Drug Free Solution's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2014 was -1,521.05%.

Drug Free Solution  (OTCPK:DSOL) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Drug Free Solution's annualized ROC % for the quarter that ended in Feb. 2014 is calculated as:

ROC % (Q: Feb. 2014 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Nov. 2013 ) + Invested Capital (Q: Feb. 2014 ))/ count )
=-0.48 * ( 1 - 0% )/( (0.184 + 0.289)/ 2 )
=-0.48/0.2365
=-202.96 %

where

Invested Capital(Q: Nov. 2013 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.05 - 0.133 - ( 0.001 - max(0, 0.268 - 0.001+0.001))
=0.184

Invested Capital(Q: Feb. 2014 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.052 - 0.147 - ( 0.007 - max(0, 0.391 - 0.007+0.007))
=0.289

Note: The Operating Income data used here is four times the quarterly (Feb. 2014) data.

2. Joel Greenblatt's definition of Return on Capital:

Drug Free Solution's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2014 is calculated as:

ROC (Joel Greenblatt) %(Q: Feb. 2014 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Nov. 2013  Q: Feb. 2014
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.48/( ( (0.038 + max(-0.268, 0)) + (0.035 + max(-0.391, 0)) )/ 2 )
=-0.48/( ( 0.038 + 0.035 )/ 2 )
=-0.48/0.0365
=-1,315.07 %

where Working Capital is:

Working Capital(Q: Nov. 2013 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0.133 + 0 + 0.135)
=-0.268

Working Capital(Q: Feb. 2014 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0.147 + 0 + 0.244)
=-0.391

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Feb. 2014) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Drug Free Solution's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Feb. 2014 )
=-0.867/0.057
=-1,521.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Drug Free Solution EBIT Related Terms

Drug Free Solution EBIT Historical Data

* Premium members only.

The historical data trend for Drug Free Solution's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Drug Free Solution EBIT Chart

Drug Free Solution Annual Data
Trend May12 May13
EBIT
-0.55 -0.76

Drug Free Solution Quarterly Data
Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Feb14
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.12 -0.57 -0.05 -0.13 -0.12

DSOL vs USEL, ZZLL, WSCO: EBIT Comparison

For the Health Information Services subindustry, Drug Free Solution's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Drug Free Solution EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Drug Free Solution's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Drug Free Solution's EV-to-EBIT falls into.


Drug Free Solution EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Feb. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.87 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-0.87 Mil mean?
Drug Free Solution (DSOL) has a EBIT of $-0.87 Mil as of Feb. 2014. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Drug Free Solution.
Is Drug Free Solution's EBIT too high?
Drug Free Solution's current EBIT is $-0.87 Mil.
How does Drug Free Solution's EBIT compare to USEL and ZZLL?
Drug Free Solution's EBIT of $-0.87 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Drug Free Solution. Drug Free Solution's current EBIT is $-0.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drug Free Solution stock overvalued right now?
Drug Free Solution (DSOL) has a current EBIT of $-0.87 Mil. The current EBIT is $-0.87 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Drug Free Solution (DSOL), the current EBIT is $-0.87 Mil as of Feb. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Drug Free Solution Business Description

Address 2211 Michelson Drive, Irvine, CA, USA, 92612
Drug Free Solution Inc is a United States based holding company that owns and operates various subsidiaries in the healthcare industry. It is focused on acquiring healthcare operations that focus on Home Healthcare, Developmental Disabilities, Hospice Care, Skilled Nursing, Residential Rehabilitation, Home & Community Based Services.